Triptolide inhibited melanoma growth by reducing Foxp3 mRNA levels in the spleen and auxiliary lymph nodes, as well as TGF-β, IL-10, VEGF and Tregs within the TME (161). The gene discussed is IL10; the disease is melanoma.